Capsule endoscopy (CE), introduced in 2000 and FDA-approved in 2001, remains a valuable tool for diagnosing gastrointestinal (GI) lesions, particularly in areas inaccessible to traditional endoscopy. While CE offers non-invasive imaging and improves detection of small bowel diseases and obscure GI bleeding, its widespread use is hindered by limitations such as lack of therapeutic capabilities, inability to obtain biopsies, reliance on peristalsis for movement, and time-consuming image interpretation.
Trending
- When GI Puts AI to Work Beyond Polyp Detection
- AI Model Detects Colorectal Cancer and Advanced Adenomas in Blood (Bioengineer)
- ACG: Anesthesia support, strategic integration of APPs needed to bolster GI workforce (Healio)
- Medicare adds specialty code for physician nutrition specialists (GI & Hepatology News)
- EnVision Endoscopy Announces Oversubscribed Series A Financing and Reaches First 50 Patient Procedures with SimpleStitch™ Suturing System (PR Newswire)
- GI centers can’t explain their cancellation spike (Becker’s GI & Endoscopy)
- Beyond Burnout: Recognizing and Reframing the Heartsink Response in Gastroenterologists and Hepatologists (Gastroenterology)
- AGA and AASLD Joint Guidelines on PBC Diagnosis and Management (Gastroenterology Advisor)
